Scarica l'app Stockscreener
20.79
7.23%
-1.62
Dopo l'orario di chiusura:
20.79
Precedente Chiudi:
$22.41
Aprire:
$19.8
Volume 24 ore:
3,473
Relative Volume:
0.85
Capitalizzazione di mercato:
$54.41M
Reddito:
$17,000
Utile/perdita netta:
$-23.87M
Rapporto P/E:
-6.6635
EPS:
-3.12
Flusso di cassa netto:
$-22.03M
1 W Prestazione:
-9.17%
1M Prestazione:
-1.82%
6M Prestazione:
+10.47%
1 anno Prestazione:
+46.00%
Intervallo 1D:
$19.80
$21.20
Intervallo di 1 settimana:
$19.80
$22.50
Portata 52W:
$12.62
$26.99
Vtv Therapeutics Inc Stock (VTVT) Company Profile
Nome
Vtv Therapeutics Inc
Settore
Industria
Telefono
336-841-0300
Indirizzo
3980 PREMIER DR, HIGH POINT, NC
Confronta VTVT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VTVT
Vtv Therapeutics Inc
|
20.79 | 57.08M | 17,000 | -23.87M | -22.03M | -3.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Vtv Therapeutics Inc Stock (VTVT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2019-05-30 | Iniziato | H.C. Wainwright | Buy |
| 2018-04-10 | Downgrade | Stifel | Buy → Hold |
| 2018-03-08 | Iniziato | ROTH Capital | Buy |
| 2018-02-08 | Iniziato | Northland Capital | Outperform |
| 2016-09-26 | Iniziato | H.C. Wainwright | Buy |
| 2015-09-04 | Iniziato | Canaccord Genuity | Buy |
| 2015-08-24 | Iniziato | Piper Jaffray | Overweight |
| 2015-08-24 | Iniziato | Stifel | Buy |
Mostra tutto
Vtv Therapeutics Inc Borsa (VTVT) Ultime notizie
Can vTv Therapeutics Inc. (5VT0) stock withstand sector downturnsEarnings Growth Summary & Free Verified High Yield Trade Plans - newser.com
vTv Therapeutics Inc 5VT0 Stock Analysis and ForecastAnalyst Downgrades & Outstanding Investment Returns - earlytimes.in
Is vTv Therapeutics Inc. stock dividend yield sustainable2025 Market Outlook & Long-Term Safe Return Strategies - newser.com
Is vTv Therapeutics Inc. stock bottoming outWeekly Trade Summary & AI Enhanced Market Trend Forecasts - newser.com
Will vTv Therapeutics Inc. benefit from macro trends2025 Top Gainers & Step-by-Step Trade Execution Guides - newser.com
How vTv Therapeutics Inc. stock compares to growth peersAnalyst Downgrade & Free High Return Stock Watch Alerts - newser.com
Evaluating vTv Therapeutics Inc. with trendline analysisWatch List & Technical Buy Zone Confirmation - newser.com
Strategies to average down on vTv Therapeutics Inc.Portfolio Risk Summary & Accurate Trade Setup Notifications - newser.com
Can vTv Therapeutics Inc. stock withstand economic slowdownTrade Volume Summary & Weekly Stock Breakout Alerts - newser.com
vTv Therapeutics (NASDAQ:VTVT) Given “Sell (D-)” Rating at Weiss Ratings - Defense World
Can a trend reversal in vTv Therapeutics Inc. lead to recoveryWeekly Gains Summary & Technical Analysis for Trade Confirmation - newser.com
Order flow analysis tools used on vTv Therapeutics Inc.CEO Change & Short-Term Trading Opportunity Alerts - newser.com
How vTv Therapeutics Inc. stock performs in rising dollar environmentMarket Sentiment Review & Safe Capital Preservation Plans - newser.com
How cyclical is vTv Therapeutics Inc. (5VT0) stock compared to rivalsDip Buying & Long-Term Safe Investment Ideas - newser.com
Applying chart zones and confluence areas to vTv Therapeutics Inc.Inflation Watch & Free Risk Controlled Daily Trade Plans - newser.com
Tools to assess vTv Therapeutics Inc.’s risk profileProfit Target & Consistent Return Investment Signals - newser.com
Published on: 2025-10-10 04:14:14 - newser.com
vTv Therapeutics appoints four new members to scientific advisory board By Investing.com - Investing.com Nigeria
vTv Therapeutics (VTVT) Expands Scientific Advisory Board with N - GuruFocus
vTv Therapeutics appoints four new members to scientific advisory board - Investing.com
vTv Therapeutics Appoints Renowned Experts to Scientific Advisory Board for Cadisegliatin Development - Quiver Quantitative
vTv Therapeutics Announces New Appointments to its Scientific Advisory Board - GlobeNewswire
Phase 3 Initiated — vTv Therapeutics Appoints 4 to SAB to Guide Cadisegliatin Development - Stock Titan
Visual analytics tools that track vTv Therapeutics Inc. performanceJuly 2025 PreEarnings & High Accuracy Investment Entry Signals - newser.com
Price action breakdown for vTv Therapeutics Inc.Trade Signal Summary & High Accuracy Trade Alerts - newser.com
Reviewing Repligen (NASDAQ:RGEN) and vTv Therapeutics (NASDAQ:VTVT) - Defense World
What drives vTv Therapeutics Inc stock pricePrice Action Trading & Outperform the Market with Aggressive Picks - earlytimes.in
Published on: 2025-10-06 05:06:17 - newser.com
Will vTv Therapeutics Inc. (5VT0) stock deliver compounding returns2025 Bull vs Bear & Weekly Breakout Watchlists - newser.com
Published on: 2025-10-01 09:02:18 - newser.com
H.C. Wainwright Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Maintains Target Price $36 - 富途牛牛
Vtv Therapeutics Inc Azioni (VTVT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):